Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, dated May 20, 2026, is a report of a foreign private issuer filed by Cellectis S.A. The filing serves to announce the upcoming Combined General Meeting of Shareholders scheduled for June 25, 2026, at 2:30 p.m. Paris time at the Biopark auditorium in Paris, France.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely addresses the logistics of the shareholder meeting.
Guidance, Outlook, and Risks
Management commentary, financial guidance, outlook, risks, contingencies, and unusual items are not discussed in this filing. Shareholders are directed to the company's website for additional information regarding the meeting.
Key Facts for Investors
- Meeting Date: June 25, 2026.
- Meeting Time: 2:30 p.m. (Paris time).
- Location: Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France.
- Document Reference: The Notice of Combined General Meeting of Shareholders is attached as Exhibit 99.1.
- Information Source: Further details are available on the Investors section of the Cellectis website.